ロード中...

Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution

BACKGROUND: Only 15–20% of pancreatic ductal adenocarcinoma (PDAC) patients are upfront surgical candidates at presentation, and for this cohort of patients, the 5-year survival is a mere 20% despite adjuvant therapy. Previous data indicate that in clinical practice most of these cases are “borderli...

詳細記述

保存先:
書誌詳細
出版年:Ann Pancreat Cancer
主要な著者: Recio-Boiles, Alejandro, Vondrak, Jessica, Veeravelli, Summana, Mancuso, James J., Saboda, Kathylynn, Roe, Denise J., Riaz, Irbaz Bin, Scott, Aaron J., Elquza, Emad, McBride, Ali, Babiker, Hani M.
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170377/
https://ncbi.nlm.nih.gov/pubmed/32313882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/apc.2020.02.01
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!